Pricing a new drug /

Exodus Pharmaceuticals, Inc. is a small pharmaceutical company with three pharmaceutical products on the market. A promising drug in late-stage clinical trials presents an opportunity for a comprehensive market access strategy including pricing and reimbursement. Rising launch prices of drugs are of...

Full description

Bibliographic Details
Main Authors:	Munshaw, Supriya (Author), Chawla, Amarpreet (Author)
Format:	eBook
Language:	English
Published:	London : SAGE Publications: SAGE Business Cases Originals, 2019.
Series:	SAGE Knowledge. Cases. SAGE research methods. Cases.
Subjects:	Exodus Pharmaceuticals, Inc. Drugs > Prices > Case studies. Pharmaceutical industry > Management. Prescription pricing. Drugs > Prices. Médicaments > Prix > Études de cas. Industrie pharmaceutique > Gestion. Médicaments > Prix. Drugs > Prices Pharmaceutical industry > Management Prescription pricing Electronic books. Case studies Case studies. Études de cas.
Online Access:	Connect to the full text of this electronic book

Description
Summary:	Exodus Pharmaceuticals, Inc. is a small pharmaceutical company with three pharmaceutical products on the market. A promising drug in late-stage clinical trials presents an opportunity for a comprehensive market access strategy including pricing and reimbursement. Rising launch prices of drugs are often cited as the primary reason for increasing U.S. prescription drug spending, making it essential to develop an evidence-based price. In this case study, students will explore how tethering the price of the drug to its value can result in optimal pricing. In doing so, students will be introduced to the concept of value-based pricing strategy and will determine the value and corresponding price of the drug as it relates to the key stakeholders, namely, patients, physicians, providers, and payers.
Physical Description:	1 online resource : illustrations.
Bibliography:	Includes bibliographical references and index.
ISBN:	9781526498601 152649860X